DR. JOSEPH LANCASTER – Trademark Portfolio

Entity Type: 01

DR. JOSEPH LANCASTER holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GNOSTIC PNEUMATHERAPY. The owner is based in Bakersfield, CA.

1011 17th Street

Bakersfield, CA 93301

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DR. JOSEPH LANCASTER's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does DR. JOSEPH LANCASTER have?

DR. JOSEPH LANCASTER has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does DR. JOSEPH LANCASTER file in?

DR. JOSEPH LANCASTER files trademarks across 2 Nice Classification classes. The most active classes are Class 45 (Legal & Security Services), Class 44 (Medical Services). Class 45 covers legal services; security services for the protection of property and individuals.

What are DR. JOSEPH LANCASTER's most well-known trademarks?

DR. JOSEPH LANCASTER's registered trademark portfolio includes well-known marks such as GNOSTIC PNEUMATHERAPY. These are among 1 currently registered trademark in the portfolio.

What is DR. JOSEPH LANCASTER's trademark registration success rate?

DR. JOSEPH LANCASTER has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.